Last $0.21 USD
Change Today -0.0162 / -7.09%
Volume 244.0K
CERE On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 01/26/15 All times are local (Market data is delayed by at least 15 minutes).

ceres inc (CERE) Key Developments

Ceres, Inc. Announces Unaudited Consolidated Financial Results for the First Quarter Ended November 30, 2014

Ceres, Inc. announced unaudited consolidated financial results for the first quarter ended November 30, 2014. Total revenues for the quarter ended November 30, 2014 were $0.4 million compared to $0.8 million for the quarter ended November 30, 2013. For the quarter, the company reported a net loss of $5.973 million, or $0.12 per basic and diluted share, compared to a net loss of $8.205 million, or $0.33 per basic and diluted share, for the quarter ended November 30, 2013. Loss from operations was $5,987,000 against $8,220,000 a year ago. Loss before income taxes was $5,972,000 against $8,204,000 a year ago period.

Ceres, Inc. to Report Q1, 2015 Results on Jan 13, 2015

Ceres, Inc. announced that they will report Q1, 2015 results at 4:30 PM, US Eastern Standard Time on Jan 13, 2015

Ceres, Inc., Q1 2015 Earnings Call, Jan 13, 2015

Ceres, Inc., Q1 2015 Earnings Call, Jan 13, 2015

Ceres, Inc. Announces Results from its Biotech Corn Evaluations in China

Ceres, Inc. announced favorable results from its biotech corn evaluations in China, where a second year of field trials demonstrated significant yield advantages under normal and drought conditions. Corn provides an additional out-licensing opportunity for traits that Ceres is developing for use in sorghum and other crops. The company reported that its multi-gene combinations in corn achieved an approximately 25% yield advantage over controls in many of its research-scale field evaluations involving two different hybrids. These replicated field evaluations were conducted in two different climatic regions in China through the company's development collaboration with the Chinese Academy of Agricultural Sciences. Field evaluations represent a critical stage in the development of biotech crop traits, as they provide greater insight into how traits may perform in an agricultural setting. The company has selected its best multi-gene combinations for broader field evaluations in 2015. The company also announced that it has developed a new, high-throughput, low-cost approach to empirically evaluate large numbers of promising genes and related control components and to select the best combinations for deployment in a crop. The company is deploying this multi-gene trait development system internally and believes there may be opportunities to out-license the system, known as iCODE, to other crop biotechnology companies.

Ceres, Inc. Announces Board Changes

Ceres, Inc. announced that Aflalo Guimaraes has joined its board of directors to serve as a Class I director of the company for a term beginning December 12, 2014 and expiring at the company's annual meeting of stockholders in 2016, to fill the vacancy on the Board created by Mr. Debbane's resignation. Mr. Guimaraes succeeds Raymond Debbane, who retired from Ceres' board. Aflalo Guimaraes is a managing director of The Invus Group, LLC. Prior to joining Invus in 1998, he was a manager at Marakon Associates where he led strategic consulting engagements for large multi-national companies in a wide range of industries, including financial services, retail and consumer products. He previously worked at the U.S. Federal Reserve. Mr. Guimaraes has also been appointed to the company's Compensation Committee and Nominating and Corporate Governance Committee. On December 12, 2014, Mr. Raymond Debbane of The Invus Group resigned from the Board of Directors of Ceres, Inc. Mr. Debbane has served on the Company's Board since March 1998. There was no disagreement with the Company on any matter relating to the Company's operations, policies or practices.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CERE:US $0.21 USD -0.0162

CERE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Advanta Ltd 343.00 INR -3.40
Illumina Inc $201.68 USD +4.52
KWS Saat AG €273.44 EUR +0.57
VIASPACE Green Energy Inc $1.00 USD 0.00
Viaspace Inc $0.0080 USD -0.0001
View Industry Companies
 

Industry Analysis

CERE

Industry Average

Valuation CERE Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 5.4x
Price/Book 0.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CERES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.